Source: Annual Congress 2013 –COPD and tobacco management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Naveed, T. Mahmud, N. H. Bokhari, M. Aasim (Lahore, Pakistan). Obscure chronic obstructive pulmonary disease in tobacco smokers having ischemic heart disease. Eur Respir J 2013; 42: Suppl. 57, 2082

Member's Comments

No comment yet.

Related content which might interest you: Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Characteristics and consequences of chronic obstructive pulmonary disease in never smokers Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 How to screen chronic obstructive pulmonary disease in general practice? Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015 Smoking abstinence in patients with chronic airway obstructive disease Source: Annual Congress 2006 - How to treat tobacco smokers Year: 2006 Clinical features of chronic obstructive pulmonary disease in never smokers Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Smoking cessation in patients with respiratory diseases Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 The questionnaire chronic obstructive pulmonary disease-population screener (COPD-PS) as a screening of the chronic obstructive pulmorary disease (COPD) in a quitting smoke medical practice Source: International Congress 2016 – Smoking cessation strategies Year: 2016 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Influence of tobacco smoking on respiratory muscles function in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 247s Year: 2006 Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Epidemiology of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 17: 982-994 Year: 2001 Chronic obstructive pulmonary disease in smokers with asthma Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission Year: 2011 Overview of smoking-related disease Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Detection of asthma and chronic obstructive pulmonary disease in primary care Source: Eur Respir J 2003; 21: 16S-22S Year: 2003 Smoking and dyspnea severity in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Passive smoking and epidemiology Year: 2017 Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Tobacco smoking habits by patients with chronic obstructive pulmonary disease (COPD) and their impact on number of hospitalizations Source: Eur Respir J 2007; 30: Suppl. 51, 169s Year: 2007 Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016